Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP.
暂无分享,去创建一个
Kuo-Chen Chou | Dong-Qing Wei | K. Chou | Dongqing Wei | Yonghua Wang | Ying-Wu Lin | Hong-li Du | Jingfang Wang | Jing-Fang Wang | Ying Lin | Yong-Hua Wang | Hong-Li Du | Yi-Xve Li | Yixuan Li
[1] R. Battiti,et al. Simulated annealing and Tabu search in the long run: A comparison on QAP tasks☆ , 1994 .
[2] K. Chou. Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.
[3] Kuo-Chen Chou,et al. Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives. , 2005, Biochemical and biophysical research communications.
[4] K. Chou,et al. Simulated annealing approach to the study of protein structures. , 1991, Protein engineering.
[5] Louise Wickham,et al. Post-translational Processing of β-Secretase (β-Amyloid-converting Enzyme) and Its Ectodomain Shedding , 2001, The Journal of Biological Chemistry.
[6] N. Green,et al. The crystal structure of an aldehyde reductase Y50F mutant-NADP complex and its implications for substrate binding. , 2001, Chemico-biological interactions.
[7] B. Nidetzky,et al. Fine tuning of coenzyme specificity in family 2 aldo‐keto reductases revealed by crystal structures of the Lys‐274 → Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NAD+ and NADP+ , 2005, FEBS letters.
[8] Fabrice Leclerc,et al. Effective atom volumes for implicit solvent models: comparison between Voronoi volumes and minimum fluctuation volumes , 2001, J. Comput. Chem..
[9] C. Hollenberg,et al. Cloning and expression in Saccharomyces cerevisiae of the NAD(P)H-dependent xylose reductase-encoding gene (XYL1) from the xylose-assimilating yeast Pichia stipitis. , 1991, Gene.
[10] K. Chou,et al. Progress in computational approach to drug development against SARS. , 2006, Current medicinal chemistry.
[11] Elaine C. Meng,et al. Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities , 1994, J. Comput. Aided Mol. Des..
[12] Kuo-Chen Chou,et al. Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase , 2004, Analytical Biochemistry.
[13] T. Penning,et al. The aldo-keto reductase superfamily homepage. , 2003, Chemico-biological interactions.
[14] Gerhard Wagner,et al. Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.
[15] K. Chou,et al. Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.
[16] Kuo-Chen Chou,et al. Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points , 2004, J. Chem. Inf. Model..
[17] Fred Glover,et al. Tabu Search: A Tutorial , 1990 .
[18] K. Chou,et al. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide , 2004, Peptides.
[19] K. Chou,et al. Molecular insights of SAH enzyme catalysis and implication for inhibitor design. , 2007, Journal of theoretical biology.
[20] K. Chou,et al. Graphic rules in steady and non-steady state enzyme kinetics. , 1989, The Journal of biological chemistry.
[21] Kuo-Chen Chou,et al. Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. , 2005, Journal of proteome research.
[22] Kuo-Chen Chou,et al. Inhibitor design for SARS coronavirus main protease based on "distorted key theory". , 2007, Medicinal chemistry (Shariqah (United Arab Emirates)).
[23] J. Kinoshita,et al. The Pharmacology of Aldose Reductase Inhibitors , 1985 .
[24] Kuo-Chen Chou,et al. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. , 2006, Biochemical and biophysical research communications.
[25] Kuo-Chen Chou,et al. Insights from modeling the tertiary structure of human BACE2. , 2004, Journal of proteome research.
[26] Louise Wickham,et al. Post-translational processing of β-secretase (BACE) and its ectodomain shedding: the pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid Aβ production , 2001 .
[27] T. A. Jones,et al. Using known substructures in protein model building and crystallography. , 1986, The EMBO journal.
[28] Kuo-Chen Chou,et al. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.
[29] D. Goodsell,et al. Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock , 2002, Proteins.
[30] Ana Martínez,et al. Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders , 2000 .
[31] Kuo-Chen Chou,et al. Identification of the N‐terminal functional domains of Cdk5 by molecular truncation and computer modeling , 2002, Proteins.
[32] M. Lewis,et al. Comparative anatomy of the aldo-keto reductase superfamily. , 1997, The Biochemical journal.
[33] Kuo-Chen Chou,et al. 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. , 2007, Biochemical and biophysical research communications.
[34] K. Chou,et al. Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.
[35] K. Chou,et al. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. , 2007, Biochemical and biophysical research communications.
[36] Kuo-Chen Chou,et al. Energy of stabilization of the right-handed βαβ crossover in proteins☆ , 1989 .
[37] V. Garsky,et al. The Pro Domain of β-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain* , 2001, The Journal of Biological Chemistry.
[38] C. Grimshaw. Aldose reductase: model for a new paradigm of enzymic perfection in detoxification catalysts. , 1992, Biochemistry.
[39] Characterization and purification of a mammalian osmoregulatory protein, aldose reductase, induced in renal medullary cells by high extracellular NaCl. , 1987, The Journal of biological chemistry.
[40] K D Watenpaugh,et al. A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.
[41] Todd J. A. Ewing,et al. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..
[42] Kuo-Chen Chou,et al. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. , 2004, Biochemical and biophysical research communications.
[43] K. Chou. Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady-state systems. , 2020, Biophysical chemistry.
[44] D. Haltrich,et al. Noncovalent enzyme-substrate interactions in the catalytic mechanism of yeast aldose reductase. , 1998, Biochemistry.
[45] Kuo-Chen Chou,et al. Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .
[46] Hung Lee,et al. Review: The structure and function of yeast xylose (aldose) reductases , 1998, Yeast.
[47] K. Chou,et al. The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties , 2006, Marine Drugs.
[48] K.-C. Chou,et al. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy , 2006, Amino Acids.
[49] K.-C. Chou,et al. Anti-SARS drug screening by molecular docking , 2006, Amino Acids.
[50] Kuo-Chen Chou,et al. Molecular modeling studies of peptide drug candidates against SARS. , 2006, Medicinal chemistry (Shariqah (United Arab Emirates)).
[51] Kuo-Chen Chou. Insights from modeling three-dimensional structures of the human potassium and sodium channels. , 2004, Journal of proteome research.
[52] Kuo-Chen Chou,et al. Modeling the tertiary structure of human cathepsin-E. , 2005, Biochemical and biophysical research communications.
[53] Kuo-Chen Chou,et al. Molecular therapeutic target for type-2 diabetes. , 2004, Journal of proteome research.
[54] David S. Goodsell,et al. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..
[55] L. Tsai,et al. Structure and Regulation of the CDK5-p25nck5a Complex , 2001 .
[56] Kuo-Chen Chou,et al. Insights from Modeling the 3D Structure of DNA−CBF3b Complex , 2005 .
[57] T. L. Blundell,et al. Knowledge-based prediction of protein structures and the design of novel molecules , 1987, Nature.
[58] Kuo-Chen Chou,et al. Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. , 2004, Biochemical and biophysical research communications.
[59] Kuo-Chen Chou,et al. The convergence‐divergence duality in lectin domains of selectin family and its implications , 1995, FEBS letters.